SNNA
Sienna Biopharmaceuticals, Inc.
SNNA
SNNA
Delisted
SNNA was delisted on the 16th of December, 2019.
43 hedge funds and large institutions have $154M invested in Sienna Biopharmaceuticals, Inc. in 2017 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 18 increasing their positions, 8 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
13% less capital invested
Capital invested by funds: $178M → $154M (-$23.9M)
Holders
43
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$5.08M | |
| 2 | +$1.27M | |
| 3 | +$1.2M | |
| 4 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$820K |
| 5 |
CCP
Clough Capital Partners
Boston,
Massachusetts
|
+$617K |
Top Sellers
| 1 | -$556K | |
| 2 | -$440K | |
| 3 | -$285K | |
| 4 |
ACM
Asymmetry Capital Management
San Francisco,
California
|
-$271K |
| 5 |
PCM
Prelude Capital Management
New York
|
-$131K |